AT290210T

Use of anti-embryonic hemoglobin antibodies to identify fetal cells

Abstract

The invention claims a or a separate the tire evaluation method of the blood sample of the living. The temporally tire coring the blood cell panel with a tire hemoglobin or the tire hemoglobin chain's specific antibody or a fragment antibody or anti-counterfeiting mark with a nuclear the blood cell panel. An and tire unit, with collects the tire nucleic acid or the protein to each of are distinguished and an. Appear is tire nucleic acid or protein for detecting designated or exist to obtain a quality or the diagnosis or the pre-natal estimation of quantitative, comprising a measuring embryo's existence of sex, chromosome, single gene or protein abnormal and a specific gene, nucleic acid sequence or protein or wireless.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

25 members in 14 offices

This recordMember, by publication datePriority claim4 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
73455696United States of AmericaA
9719447United States of AmericaW

Members25

Family members, oldest first
DocumentOfficeKind
US5731156AUnited States of AmericaA
CA2269327A1CanadaA1
WO9818005A1World Intellectual Property Organization (WIPO)A1
AU4920097AAustraliaA
US5962234AUnited States of AmericaA
CN1234117AChinaA
BR9712548ABrazilA
IL129382D0IsraelD0
EP1007965A1European Patent Office (EPO)A1
EP1007965A4European Patent Office (EPO)A4
KR20000052662ARepublic of KoreaA
JP2001502805AJapanA
HK1031255A1Hong Kong, ChinaA1
AU735380B2AustraliaB2
RU2178703C2Russian FederationC2
IL145691D0IsraelD0
IL129382AIsraelA
IL145691AIsraelA
EP1007965B1European Patent Office (EPO)B1
AT290210TThis recordAustriaT
ATE290210T1AustriaT1
DE69732662D1GermanyD1
KR100523381B1Republic of KoreaB1
DE69732662T2GermanyT2
JP4091123B2JapanB2